Will Hydroxychloroquine Impede or Prevent COVID-19

NCT04341441 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

624

Enrollment

OTHER

Sponsor class

Stopped Interim analysis did not reveal any safety concerns by the DSMB, but unblinded data did not provide support to continue. Event rate did not meet projected magnitude; given low recruitment potential, it is unlikely that a positive result will occur.

Conditions

COVID-19
Coronavirus
Coronavirus Infections
SARS-CoV 2

Interventions

DRUG: Hydroxychloroquine - Daily Dosing
DRUG: Hydroxychloroquine - Weekly Dosing
OTHER: Placebo oral tablet
DIAGNOSTIC_TEST: Monitoring Visit - Baseline
DIAGNOSTIC_TEST: Monitoring Visit - Week 4
DIAGNOSTIC_TEST: Monitoring Visit - Week 8
OTHER: Weekly Assessment

Sponsor

Henry Ford Health System